SCHEMBL671719

SCHEMBL671719

C=CC1CCCCC1C=C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1560875 1.00 ALDH1A1 (0.31) ALDH1A1MAPTTDP1
SCHEMBL1560870 1.00 ALDH1A1 (0.31) ALDH1A1MAPTTDP1
SCHEMBL1560867 1.00 ALDH1A1 (0.31) ALDH1A1MAPTTDP1
SCHEMBL17798840 0.96 ALDH1A1 (0.31) ALDH1A1
SCHEMBL7984377 0.92
SCHEMBL7984375 0.92
SCHEMBL14639642 0.85 ADH1A (0.31)
SCHEMBL14639774 0.85 ADH1A (0.31)
SCHEMBL1263403 0.84
SCHEMBL3679724 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 572 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11680312-B2 Catalyst enhanced seamless ruthenium gap fill APPLIED MATERIALS, INC. (US) 2023-06-20 US claimed
US-20220333232-A1 CATALYST ENHANCED SEAMLESS RUTHENIUM GAP FILL APPLIED MATERIALS, INC. (US) 2022-10-20 US claimed
US-11401602-B2 Catalyst enhanced seamless ruthenium gap fill APPLIED MATERIALS, INC. (US) 2022-08-02 US claimed
US-20210214842-A1 CATALYST ENHANCED SEAMLESS RUTHENIUM GAP FILL APPLIED MATERIALS, INC. (US) 2021-07-15 US claimed
US-7214747-B2 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US claimed
US-7214746-B2 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-05-08 US claimed
EP-1737893-A1 PHOSPHORUS BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION ExxonMobil Chemical Patents Inc. (US) 2007-01-03 EP claimed
EP-1737875-A1 PHOSPHORUS SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION Exxonmobil Chemical Patents Inc. (US) 2007-01-03 EP claimed
WO-2005108410-A1 PHOSPHORUS SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-11-17 WO claimed
WO-2005108435-A1 PHOSPHORUS BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-11-17 WO claimed
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US claimed
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2005-10-27 US claimed
US-6627720-B2 Monoethylenically unsaturated monomers are polymerized with at least one multiethylenically unsaturated monomer at high temperatures by free radical polymerization in a continuous reactor, without formation of highly crosslinked gels JOHNSON POLYMER, LLC 2003-09-30 US claimed
EP-0977808-B1 AMORPHOUS PROPYLENE-POLYENE COPOLYMERS AND COMPOSITIONS THEREOF DOW CHEMICAL CO (US) 2002-10-16 EP claimed
US-20010053838-A1 Terminal olefin functionalized macromonomers FMC CORPORATION 2001-12-20 US claimed
WO-2001070832-A2 TERMINAL OLEFIN FUNCTIONALIZED MACROMONOMERS FMC CORPORATION (US) 2001-09-27 WO claimed
US-6265511-B1 BLEND OF DIVINYL MONOMER AND MONOETHYLENICALLY UNSATURATED MONOMER S. C. JOHNSON COMMERICAL MARKETS, INC. 2001-07-24 US claimed
EP-0977808-A1 AMORPHOUS PROPYLENE-POLYENE COPOLYMERS AND COMPOSITIONS THEREOF THE DOW CHEMICAL COMPANY (US) 2000-02-09 EP claimed
WO-1998049229-A1 AMORPHOUS PROPYLENE-POLYENE COPOLYMERS AND COMPOSITIONS THEREOF THE DOW CHEMICAL COMPANY (US) 1998-11-05 WO claimed
EP-0187958-A2 Resin for information recording medium TORAY INDUSTRIES, INC. (JP) 1986-07-23 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239981-A1 Phosphorus bridged metallocene compounds for olefin polymerization PYM1, ZNF207, POLL ALDH1A1 4206/4885MAPT 778/4885TDP1 3496/4885
US-20050239980-A1 Phosphorus substituted metallocene compounds for olefin polymerization CCRL2, ARL1, OSBP2 ALDH1A1 4248/4885MAPT 3649/4885TDP1 4547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.